Optimal selection of antiemetics in children receiving cancer chemotherapy

Supportive Care in Cancer

Volumn 6, Issue 3, 1998, Pages 215-220

  Roila, Fausto ^a   Aapro, Matti ^b   Stewart, Alan ^c  

^a Policlinico Hospital   (Italy)

^b CLINIQUE DE GENOLIER   (Switzerland)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Antiemetics in children; Cancer chemotherapy

Indexed keywords

DEXAMETHASONE; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; SEROTONIN 3 ANTAGONIST;

ANTIEMETIC ACTIVITY; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; DROWSINESS; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PRIORITY JOURNAL; REVIEW; SEDATION; VOMITING;

ANTIEMETICS; CHILD; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; NAUSEA; NEOPLASMS; PALLIATIVE CARE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 0031948314     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050156     Document Type: Review

References (39)

1. Allen JC, Gralla R, Reilly L, Kellick M, Young C (1985) Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 3:1136-1141
2. Alvarez O, Freeman A, Bedroh A, Call SK, Volsch J, Kalbermatter O, Halverson J, Convoy L, Cook L, Mick K, Zimmerman G (1995) Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in paediatric patients with malignancies. J Pediatr Hematol Oncol 17:145-150
3. Benoit Y, Hulstaert F, Vermylen C, Sariban E, Hoyoux C, Uyttebroeck A, Otten J, Laureys C, De Kerpel I, Nortier D, Ritter L, De Keyser P (1995) Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy. Med Pediatr Oncol 25:457-462
4. Berberoglu S (1995) Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin Pediatr Hematol Oncol 12:479-483
5. Garden PA, Mitchell SL, Waters KD, Tiedemann K, Eken H (1990) Prevention of cyclophosphamide-cytarabine-induced emesis with ondansetron in children with leukaemia. J Clin Oncol 8:1531-1535
6. Cefalo G, Rottoli L, Armiraglio A, Pagan MG (1994) Tropisetron (ICS 205-930) in paediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments. Am J Pediatr Hematol Oncol 16:242-245
7. Chan HSL, MacLeod SM, Correia JA (1987) Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Paediatrics 79:946-952
8. Craft AW, Price L, Eden OB, Shaw P, Campbell R, Pierce DM, Murdoch R, Upward J (1995) Granisetron as antiemetic therapy in children with cancer. Med Pediatr Oncol 25:28-32
9. Dalzell AM, Bartlett H, Lilleyman JS (1986) Nabilone: an alternative antiemetic for cancer chemotherapy. Arch Dis Child 61:502-505
10. Dick GS, Meller ST, Pinkerton CR (1995) Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child 73:243-245
11. Ekert H, Waters KD, Jurg IH, Mobilia J, Loughnan P (1979) Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust 2:657-659
12. Gershanovich M, Kolygin B, Pirgach N (1993) Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children. Ann Oncol 4 [Suppl 3]:35-37
13. Graham-Pole J, Engel S (1984) Dose-related extrapyramidal effect of metoclopramide in children receiving chemotherapy. Proc Am Soc Clin Oncol 3:104
14. Graham-Pole J, Weare J, Engel S, Gardner R, Metha P, Gross S (1986) Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomised study of metoclopramide with chlorpromazine. J Clin Oncol 4:1110-1113
15. Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW, Bordin LA, Braun TJ, Young CW (1981) Antiemetic efficacy of high-dose metoclopramide: randomised trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305:905-909
16. Hachimi-Idrissi S, De Schepper J, Maurus R, Otten J (1993) Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy. Eur J Cancer 29A:854-856
17. Hählen K, Quintana E, Pinkerton CR, Cedar E (1995) A randomised comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children. J Pediatr 126:309-313
18. Hewitt M, McQuade B, Stevens R (1993) The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children. Clin Oncol 5:11-14
19. Hirota T, Honjo T, Kuroda R, Saeki K, Katano N, Sakakibara Y, Shimizu H, Fujimoto T (1993) Antiemetic efficacy of granisetron in paediatric cancer treatment. Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis. Gan To Kagaku Ryoho 20:2369-2373
20. Holdsworth MT, Raisch DW, Duncan MH, Chavez CM, Leasure MM (1995) Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in paediatric outpatients with leukaemia. Ann Pharmacother 29:16-21
21. Jacobson SJ, Shore RW, Greenberg M, Spielberg SP (1994) The efficacy and safety of granisetron in paediatric cancer patients who had failed standard antiemetic therapy during anticancer chemotherapy. Am J Pediatr Hematol Oncol 16:231-235
22. Jurgens H, McQuade B (1992) Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 49:279-285
23. LeBaron S, Zeltzer LK, LeBaron C, Scott SE, Zeltzer PM (1988) Chemotherapy side effects in paediatric oncology patients: drugs, age, and sex as risk factors. Med Pediatr Oncol 16:269-270
24. Leclerc JM, Jacobson SJ, Cohn R, Pinkerton CR, Mee D, Nishimura L, Cedar E (1993) A double-blind dose-ranging study of i.v. granisetron in children undergoing highly emetogenic chemotherapy. Proc Am Soc Clin Oncol 12:437
25. Leclerc JM, Greenberg M, Lau R, Ingram L, Grant R, Howard D, Lariviere L, Perrotta M, Dempsey E (1995) Open label i.v. dolasetron mesylate in paediatric patients receiving moderately to highly emetogenic chemotherapy: pharmacokinetics, efficacy and safety. Support Care Cancer 3:343
26. Lemerle J, Amaral D, Southall DP, Upward J, Murdoch RD (1991) Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients. Eur J Cancer 27:1081-1083
27. Marshall G, Kerr S, Vowels M, O'Gorman-Hughes D, White L (1989) Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. J Pediatr 115:156-160
28. Metha P, Gross S, Graham-Pole J, Gardner R (1986) Methylprednisolone for chemotherapy induced emesis: a double-blind randomized trial in children. J Pediatr 108:774-776
29. Miyajima Y, Numata S, Katayama I, Horibe K (1994) Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol 16:236-241
30. Ninane J, Ozkaynak F, Kurtin P, Siegel SE (1995) Variation in the use of ondansetron as an antiemetic drug in children treated with chemotherapy. Med Pediatr Oncol 25:33-37
31. Panzarella C, Sallan SE, Carron GJ, House KW (1994) Intravenous plus oral ondansetron for prevention of emesis in children receiving chemotherapy. Proc Am Soc Clin Oncol 13:468
32. Patel N, Hunt J, McElwain T (1983) A comparison of the antiemetic efficacy and safety of nabilone and prochlorperazine in paediatric patients with cytotoxic-induced nausea and vomiting. Proceedings of the Second European Conference on Clinical Oncology, Amsterdam, 1983, 299
33. ®) in controlling emesis induced in children by anti-cancer therapy. Tumori 80:459-463
34. Suarez A, Stettler ER, Rey E, Pons G, Simonetta-Chateauneuf C, de Bruijn KM, Olive G, Lemerle J (1994) Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy. Eur J Cancer 30A: 1436-1441
35. Sullivan MJ, Abbott GD, Robinson BA (1992) Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children. NZ Med J 105:369-371
36. Swann IL, Thompson EN, Qureshi K (1979) Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting. Br Med J 2:1979
37. Terrin BN, McWilliams NB, Maurer HM (1984) Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatr 104:138-140
38. Yanofsky R, Pyesmany A, Pritchard S, Leclerc SM, Pratt CB, Baker D, Howard D, Larivière L, Perrotta M, Dempsey E (1995) Open label oral dolasetron mesylate in paediatric patients receiving moderately to highly emetogenic chemotherapy: pharmacokinetics, efficacy and safety. Support Care Cancer 3:344
39. Zeltzer L, LeBaron S, Zeltzer PM (1984) Paradoxical effects of prophylactic phenothiazine antiemetics in children receiving chemotherapy. J Clin Oncol 2:930-936